Survival Benefits From Surgery for Stage IVa Head and Neck Squamous Cell Carcinoma: A Multi-institutional Analysis of 1,033 Cases
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives. Head and neck squamous cell carcinomas (HNSCs) are frequently diagnosed at the locoregional advanced stage (stage IVa), but controversy remains regarding whether stage IVa HSNCs should be treated with upfront surgery or definitive chemoradiation therapy (CRT). The purpose of this study was to compare overall survival (OS) and disease-free survival (DFS) in patients with stage IVa HNSC treated primarily by surgery with curative intent with/without (neo)adjuvant treatment (surgery group) versus those treated primarily with CRT (CRT group). Methods. We reviewed data of 1,033 patients with stage IVa HNSC treated with curative intent at 17 cancer centers between 2010 and 2016. Results. Among 1,033 patients, 765 (74.1%) received upfront surgery and 268 (25.9%) received CRT. The 5-year OS and DFS rates were 64.4% and 62.0% in the surgery group and 49.5% and 45.4% in the CRT group, respectively. In multivariate analyses, OS and DFS were better in the surgery group than in the CRT group (odds ratio [OR] for death, 0.762; 95% confidence interval [CI], 0.592–0.981; OR for recurrence, 0.628; 95% CI, 0.492–0.802). In subgroup analyses, the OS and DFS of patients with oropharyngeal cancer were better in the surgery group (OR for death, 0.548; 95% CI, 0.341–0.879; OR for recurrence, 0.598; 95% CI, 0.377–0.948). In the surgery group, patients with laryngeal cancer showed better OS (OR for death, 0.432; 95% CI, 0.211–0.882), while those with hypopharyngeal cancer DFS was improved (OR for recurrence, 0.506; 95% CI, 0.328–0.780). Conclusion. A survival benefit from surgery may be achieved even in patients with stage IVa HNSC, particularly those with oropharyngeal and laryngeal cancer. Surgery led to a reduction in the recurrence rate in patients with hypopharyngeal cancer.
Abstract
Objectives. Head and neck squamous cell carcinomas (HNSCs) are frequently diagnosed at the locoregional advanced stage (stage IVa), but controversy remains regarding whether stage IVa HSNCs should be treated with upfront surgery or definitive chemoradiation therapy (CRT). The purpose of this study was to compare overall survival (OS) and disease-free survival (DFS) in patients with stage IVa HNSC treated primarily by surgery with curative intent with/without (neo)adjuvant treatment (surgery group) versus those treated primarily with CRT (CRT group). Methods. We reviewed data of 1,033 patients with stage IVa HNSC treated with curative intent at 17 cancer centers between 2010 and 2016. Results. Among 1,033 patients, 765 (74.1%) received upfront surgery and 268 (25.9%) received CRT. The 5-year OS and DFS rates were 64.4% and 62.0% in the surgery group and 49.5% and 45.4% in the CRT group, respectively. In multivariate analyses, OS and DFS were better in the surgery group than in the CRT group (odds ratio [OR] for death, 0.762; 95% confidence interval [CI], 0.592–0.981; OR for recurrence, 0.628; 95% CI, 0.492–0.802). In subgroup analyses, the OS and DFS of patients with oropharyngeal cancer were better in the surgery group (OR for death, 0.548; 95% CI, 0.341–0.879; OR for recurrence, 0.598; 95% CI, 0.377–0.948). In the surgery group, patients with laryngeal cancer showed better OS (OR for death, 0.432; 95% CI, 0.211–0.882), while those with hypopharyngeal cancer DFS was improved (OR for recurrence, 0.506; 95% CI, 0.328–0.780). Conclusion. A survival benefit from surgery may be achieved even in patients with stage IVa HNSC, particularly those with oropharyngeal and laryngeal cancer. Surgery led to a reduction in the recurrence rate in patients with hypopharyngeal cancer.
참고문헌 (28)
- Vigneswaran N, "Epidemiologic trends in head and neck cancer and aids in diagnosis", Oral Maxillofac Surg Clin North Am, 26(2), pp.123~141 (2014)
- Bray F, "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68(6), pp.394~424 (2018)
- Thompson-Harvey A, "Rising incidence of late-stage head and neck cancer in the United States", Cancer, 126(5), pp.1090~1101 (2020)
- Gatta G, "Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study", Eur J Cancer, 51(15), pp.2130~2143 (2015)
- Denis F, "Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma", J Clin Oncol, 22(1), pp.69~76 (2004)
- Lefebvre JL, "Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group", J Natl Cancer Inst, 88(13), pp.890~899 (1996)
- Forastiere AA, "Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer", J Clin Oncol, 31(7), pp.845~852 (2013)
- Chaukar DA, "Quality of life in head and neck cancer survivors: a cross-sectional survey", Am J Otolaryngol, 30(3), pp.176~180 (2009)
- Iyer NG, "Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.", Cancer, 121(10), pp.1599~1607 (2015)
- Spiotto MT, "Differences in survival with surgery and postoperative radiotherapy compared with definitive chemoradiotherapy for oral cavity cancer: a national cancer database analysis", JAMA Otolaryngol Head Neck Surg, 143(7), pp.691~699 (2017)
- Gore SM, "Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma", Head Neck, 37(4), pp.518~523 (2015)
- D’Souza G, "Case-control study of human papillomavirus and oropharyngeal cancer", N Engl J Med, 356(19), pp.1944~1956 (2007)
- Keane FK, "Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era", Cancer, 121(15), pp.2594~2602 (2015)
- Song S, "Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study", BMC Cancer, 17(1), pp.598~ (2017)
- Zenga J, "Treatment outcomes for T4 oropharyngeal squamous cell carcinoma", JAMA Otolaryngol Head Neck Surg, 141(12), pp.1118~1127 (2015)
- Kelly JR, "Comparison of survival outcomes among human papillomavirus-negative cT1-2 N1-2b patients with oropharyngeal squamous cell cancer treated with upfront surgery vs definitive chemoradiation therapy: an observational study", JAMA Oncol, 3(8), pp.1107~1111 (2017)
- Roden DF, "Triple-modality treatment in patients with advanced stage tonsil cancer", Cancer, 123(17), pp.3269~3276 (2017)
- Department of Veterans Affairs Laryngeal Cancer Study Group, "Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer", N Engl J Med, 324(24), pp.1685~1690 (1991)
- Forastiere AA, "Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer", N Engl J Med, 349(22), pp.2091~2098 (2003)
- Chen AY, "Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007", Arch Otolaryngol Head Neck Surg, 137(10), pp.1017~1024 (2011)
- Chen AY, "Factors predictive of survival in advanced laryngeal cancer", Arch Otolaryngol Head Neck Surg, 133(12), pp.1270~1276 (2007)
- Patel SA, "Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer", Cancer, 125(19), pp.3367~3377 (2019)
- Dziegielewski PT, "Primary total laryngectomy versus organ preservation for T3", T4a laryngeal cancer: a population-based analysis of survival, 2012, pp.41(Suppl 1), S56~S64
- Tang ZX, "Efficacy comparison between primary total laryngectomy and nonsurgical organ-preservation strategies in treatment of advanced stage laryngeal cancer: a meta-analysis", Medicine (Baltimore), 97(21), pp.e10625~ (2018)
- Chung EJ, "Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III", IV hypopharyngeal cancer: multicenter review of 266 cases, 2019, pp.89, 84~94
- 김준원, "Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III", IV Hypopharyngeal Cancer, 2016, pp.48(1), 45~53[DOI]
- Iwae S, "Matched-pair analysis of patients with advanced hypopharyngeal cancer: surgery versus concomitant chemoradiotherapy", Int J Clin Oncol, 22(6), pp.1001~1008 (2017)
- Vengaloor Thomas T, "Management of advanced-stage hypopharyngeal carcinoma: 25-year experience from a tertiary care medical center", Cureus, 12(1), pp.e6679~ (2020)